Idera Pharmaceuticals, Inc.

IDRA · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$23$98-$113-$57
Dep. & Amort.$0$0$0$0
Deferred Tax-$6$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$0-$1-$3
Other Non-Cash$3-$126$76$11
Operating Cash Flow-$24-$25-$34-$44
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$12-$45
Inv. Sales/Matur.$0$5$10$42
Other Inv. Act.$5$0$0$0
Investing Cash Flow$5$5-$2-$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued-$0$0$29$15
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$19$29$15
Financing Cash Flow-$1$19$29$15
Forex Effect$0$0$0$0
Net Chg. in Cash-$21-$1-$7-$31
Supplemental Information
Beg. Cash$33$33$40$71
End Cash$12$33$33$40
Free Cash Flow-$24-$25-$34-$45